Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014–present)

Journal article

Aiken SG. et al, (2025), Expert Opinion on Therapeutic Patents, 1 - 11

Amenamevir by Ugi-4CR

Journal article

Li X. et al, (2023), GREEN CHEMISTRY

Amenamevir by Ugi-4CR (vol 25, pg 1322, 2023)

Journal article

Li X. et al, (2023), GREEN CHEMISTRY, 25, 4137 - 4137

Local Anesthetics via Multicomponent Reactions.

Journal article

Thomaidi M. et al, (2022), ChemMedChem, 17

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors.

Journal article

Nizami S. et al, (2021), Immunology, 162, 84 - 91

TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.

Journal article

Kunig VBK. et al, (2020), Angewandte Chemie (International ed. in English), 59, 20338 - 20342

Multicomponent Reactions: "Kinderleicht"

Journal article

Neochoritis CG. et al, (2020), Journal of Chemical Education, 97, 3739 - 3745

Load More